VeonGen Therapeutics GmbH

Biotechnology ResearchBavaria, Germany2-10 Employees

VeonGen Therapeutics (formerly known as ViGeneron) was founded in 2017 as a spin-off of the Ludwig-Maximilians-University (LMU) Munich.
At VeonGen Therapeutics we are dedicated to develop innovative gene therapies based on our two unique and proprietary technology platforms.

VeonGen Therapeutics will leverage its two technology platforms to address unmet medical needs with in-house gene therapy programs for selected retinal disorders.

Together with partners we will exploit our VeonGen Therapeutics technologies for additional indications.

Sign up for free to view info

Email Format Employee directory